Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Dynavax Technologies Corporation stock | $8.2

Learn how to easily invest in Dynavax Technologies Corporation stock.

Dynavax Technologies Corporation is a biotechnology business based in the US. Dynavax Technologies Corporation shares (DVAX) are listed on the NASDAQ and all prices are listed in US Dollars. Dynavax Technologies Corporation employs 245 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Dynavax Technologies Corporation

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – DVAX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Dynavax Technologies Corporation stock price (NASDAQ: DVAX)

Use our graph to track the performance of DVAX stocks over time.

Dynavax Technologies Corporation shares at a glance

Information last updated 2021-07-30.
Latest market close$8.20
52-week range$3.58 - $11.84
50-day moving average $9.36
200-day moving average $8.93
Wall St. target price$18.67
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.56

Buy Dynavax Technologies Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, ETFs
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Options, ETFs
$0 per year
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Dynavax Technologies Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dynavax Technologies Corporation price performance over time

Historical closes compared with the close of $8.2 from 2021-05-28

1 week (2021-07-25) N/A
1 month (2021-07-02) -17.17%
3 months (2021-05-05) -8.28%
6 months (2021-02-01) N/A
1 year (2020-08-01) N/A
2 years (2019-08-01) N/A
3 years (2018-08-01) N/A
5 years (2016-08-01) N/A

Dynavax Technologies Corporation financials

Revenue TTM $119 million
Gross profit TTM $6.5 million
Return on assets TTM -3.27%
Return on equity TTM -110.68%
Profit margin -51.91%
Book value $0.87
Market capitalisation $1.1 billion

TTM: trailing 12 months

Shorting Dynavax Technologies Corporation shares

There are currently 18.1 million Dynavax Technologies Corporation shares held short by investors – that's known as Dynavax Technologies Corporation's "short interest". This figure is 3.4% up from 17.5 million last month.

There are a few different ways that this level of interest in shorting Dynavax Technologies Corporation shares can be evaluated.

Dynavax Technologies Corporation's "short interest ratio" (SIR)

Dynavax Technologies Corporation's "short interest ratio" (SIR) is the quantity of Dynavax Technologies Corporation shares currently shorted divided by the average quantity of Dynavax Technologies Corporation shares traded daily (recently around 2.0 million). Dynavax Technologies Corporation's SIR currently stands at 9.27. In other words for every 100,000 Dynavax Technologies Corporation shares traded daily on the market, roughly 9270 shares are currently held short.

However Dynavax Technologies Corporation's short interest can also be evaluated against the total number of Dynavax Technologies Corporation shares, or, against the total number of tradable Dynavax Technologies Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Dynavax Technologies Corporation's short interest could be expressed as 0.17% of the outstanding shares (for every 100,000 Dynavax Technologies Corporation shares in existence, roughly 170 shares are currently held short) or 0.1799% of the tradable shares (for every 100,000 tradable Dynavax Technologies Corporation shares, roughly 180 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Dynavax Technologies Corporation.

Find out more about how you can short Dynavax Technologies Corporation stock.

Dynavax Technologies Corporation share dividends

We're not expecting Dynavax Technologies Corporation to pay a dividend over the next 12 months.

Have Dynavax Technologies Corporation's shares ever split?

Dynavax Technologies Corporation's shares were split on a 1:10 basis on 9 November 2014. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Dynavax Technologies Corporation shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Dynavax Technologies Corporation shares which in turn could have impacted Dynavax Technologies Corporation's share price.

Dynavax Technologies Corporation share price volatility

Over the last 12 months, Dynavax Technologies Corporation's shares have ranged in value from as little as $3.58 up to $11.84. A popular way to gauge a stock's volatility is its "beta".

DVAX.US volatility(beta: 1.23)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Dynavax Technologies Corporation's is 1.2345. This would suggest that Dynavax Technologies Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Dynavax Technologies Corporation overview

Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd. ; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996.

Stocks similar to Dynavax Technologies Corporation

Frequently asked questions

What percentage of Dynavax Technologies Corporation is owned by insiders or institutions?
Currently 0.391% of Dynavax Technologies Corporation shares are held by insiders and 74.535% by institutions.
How many people work for Dynavax Technologies Corporation?
Latest data suggests 245 work at Dynavax Technologies Corporation.
When does the fiscal year end for Dynavax Technologies Corporation?
Dynavax Technologies Corporation's fiscal year ends in December.
Where is Dynavax Technologies Corporation based?
Dynavax Technologies Corporation's address is: 2100 Powell Street, EmeryVille, CA, United States, 94608
What is Dynavax Technologies Corporation's ISIN number?
Dynavax Technologies Corporation's international securities identification number is: US2681582019
What is Dynavax Technologies Corporation's CUSIP number?
Dynavax Technologies Corporation's Committee on Uniform Securities Identification Procedures number is: 268158102

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site